Cargando…

Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis

BACKGROUND: [(18) F]fluorodopa (FDOPA) positron emission tomography (PET) allows assessment of levodopa (LDOPA) metabolism and is widely used to study Parkinson's disease. We examined how [(18) F]FDOPA PET-derived kinetic parameters relate the dopamine (DA) and DA metabolite content of extracel...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Matthew D, Dinelle, Katherine, Kornelsen, Rick, Lee, Anna, Farrer, Matthew J, Stoessl, A Jon, Sossi, Vesna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875899/
https://www.ncbi.nlm.nih.gov/pubmed/24088510
http://dx.doi.org/10.1186/2191-219X-3-69
_version_ 1782297425926422528
author Walker, Matthew D
Dinelle, Katherine
Kornelsen, Rick
Lee, Anna
Farrer, Matthew J
Stoessl, A Jon
Sossi, Vesna
author_facet Walker, Matthew D
Dinelle, Katherine
Kornelsen, Rick
Lee, Anna
Farrer, Matthew J
Stoessl, A Jon
Sossi, Vesna
author_sort Walker, Matthew D
collection PubMed
description BACKGROUND: [(18) F]fluorodopa (FDOPA) positron emission tomography (PET) allows assessment of levodopa (LDOPA) metabolism and is widely used to study Parkinson's disease. We examined how [(18) F]FDOPA PET-derived kinetic parameters relate the dopamine (DA) and DA metabolite content of extracellular fluid measured by microdialysis to aid in the interpretation of data from both techniques. METHODS: [(18) F]FDOPA PET imaging and microdialysis measurements were performed in unilaterally 6-hydroxydopamine-lesioned rats (n = 8) and normal control rats (n = 3). Microdialysis testing included baseline measurements and measurements following acute administration of LDOPA. PET imaging was also performed using [(11)C]dihydrotetrabenazine (DTBZ), which is a ligand for the vesicular monoamine transporter marker and allowed assessment of denervation severity. RESULTS: The different methods provided highly correlated data. Lesioned rats had reduced DA metabolite concentrations ipsilateral to the lesion (p < 0.05 compared to controls), with the concentration being correlated with FDOPA's effective distribution volume ratio (EDVR; r = 0.86, p < 0.01) and DTBZ's binding potential (BP(ND); r = 0.89, p < 0.01). The DA metabolite concentration in the contralateral striatum of severely (>80%) lesioned rats was lower (p < 0.05) than that of less severely lesioned rats (<80%) and was correlated with the ipsilateral PET measures (r = 0.89, p < 0.01 for BP(ND)) but not with the contralateral PET measures. EDVR and BP(ND) in the contralateral striatum were not different from controls and were not correlated with the denervation severity. CONCLUSIONS: The demonstrated strong correlations between the PET and microdialysis measures can aid in the interpretation of [(18) F]FDOPA-derived kinetic parameters and help compare results from different studies. The contralateral striatum was affected by the lesioning and so cannot always serve as an unaffected control.
format Online
Article
Text
id pubmed-3875899
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer
record_format MEDLINE/PubMed
spelling pubmed-38758992013-12-31 Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis Walker, Matthew D Dinelle, Katherine Kornelsen, Rick Lee, Anna Farrer, Matthew J Stoessl, A Jon Sossi, Vesna EJNMMI Res Original Research BACKGROUND: [(18) F]fluorodopa (FDOPA) positron emission tomography (PET) allows assessment of levodopa (LDOPA) metabolism and is widely used to study Parkinson's disease. We examined how [(18) F]FDOPA PET-derived kinetic parameters relate the dopamine (DA) and DA metabolite content of extracellular fluid measured by microdialysis to aid in the interpretation of data from both techniques. METHODS: [(18) F]FDOPA PET imaging and microdialysis measurements were performed in unilaterally 6-hydroxydopamine-lesioned rats (n = 8) and normal control rats (n = 3). Microdialysis testing included baseline measurements and measurements following acute administration of LDOPA. PET imaging was also performed using [(11)C]dihydrotetrabenazine (DTBZ), which is a ligand for the vesicular monoamine transporter marker and allowed assessment of denervation severity. RESULTS: The different methods provided highly correlated data. Lesioned rats had reduced DA metabolite concentrations ipsilateral to the lesion (p < 0.05 compared to controls), with the concentration being correlated with FDOPA's effective distribution volume ratio (EDVR; r = 0.86, p < 0.01) and DTBZ's binding potential (BP(ND); r = 0.89, p < 0.01). The DA metabolite concentration in the contralateral striatum of severely (>80%) lesioned rats was lower (p < 0.05) than that of less severely lesioned rats (<80%) and was correlated with the ipsilateral PET measures (r = 0.89, p < 0.01 for BP(ND)) but not with the contralateral PET measures. EDVR and BP(ND) in the contralateral striatum were not different from controls and were not correlated with the denervation severity. CONCLUSIONS: The demonstrated strong correlations between the PET and microdialysis measures can aid in the interpretation of [(18) F]FDOPA-derived kinetic parameters and help compare results from different studies. The contralateral striatum was affected by the lesioning and so cannot always serve as an unaffected control. Springer 2013-10-02 /pmc/articles/PMC3875899/ /pubmed/24088510 http://dx.doi.org/10.1186/2191-219X-3-69 Text en Copyright © 2013 Walker et al.; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Walker, Matthew D
Dinelle, Katherine
Kornelsen, Rick
Lee, Anna
Farrer, Matthew J
Stoessl, A Jon
Sossi, Vesna
Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis
title Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis
title_full Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis
title_fullStr Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis
title_full_unstemmed Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis
title_short Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis
title_sort measuring dopaminergic function in the 6-ohda-lesioned rat: a comparison of pet and microdialysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875899/
https://www.ncbi.nlm.nih.gov/pubmed/24088510
http://dx.doi.org/10.1186/2191-219X-3-69
work_keys_str_mv AT walkermatthewd measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis
AT dinellekatherine measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis
AT kornelsenrick measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis
AT leeanna measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis
AT farrermatthewj measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis
AT stoesslajon measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis
AT sossivesna measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis